Univariate analysis of graft characteristics as risk factors for clinical extensive chronic graft-versus-host disease
| Factor . | No. patients . | Chronic GVHD HR (95% CI)3-150 . | P . |
|---|---|---|---|
| Total nucleated cells | |||
| Less than 1 × 109/kg | 73 | 1.0 | .02 |
| At least 1 × 109/kg | 43 | 1.8 (1.1-2.9) | |
| CD34+ cells | |||
| Less than 8 × 106/kg | 84 | 1.0 | |
| At least 8 × 106/kg | 32 | 1.6 (0.9-2.7) | .08 |
| CD3+cells | |||
| Less than 3 × 108/kg | 84 | 1.0 | |
| At least 3 × 108/kg | 32 | 1.2 (0.7-2.0) | .4 |
| CD56+cells | |||
| Less than 4 × 107/kg | 87 | 1.0 | |
| At least 4 × 107/kg | 29 | 1.1 (0.6-1.8) | .8 |
| Factor . | No. patients . | Chronic GVHD HR (95% CI)3-150 . | P . |
|---|---|---|---|
| Total nucleated cells | |||
| Less than 1 × 109/kg | 73 | 1.0 | .02 |
| At least 1 × 109/kg | 43 | 1.8 (1.1-2.9) | |
| CD34+ cells | |||
| Less than 8 × 106/kg | 84 | 1.0 | |
| At least 8 × 106/kg | 32 | 1.6 (0.9-2.7) | .08 |
| CD3+cells | |||
| Less than 3 × 108/kg | 84 | 1.0 | |
| At least 3 × 108/kg | 32 | 1.2 (0.7-2.0) | .4 |
| CD56+cells | |||
| Less than 4 × 107/kg | 87 | 1.0 | |
| At least 4 × 107/kg | 29 | 1.1 (0.6-1.8) | .8 |
See Table 2 footnote.